BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33912731)

  • 21. Blurry boundaries: do epithelial borderline lesions of the breast and ductal carcinoma in situ have similar rates of subsequent invasive cancer?
    Choi DX; Eaton AA; Olcese C; Patil S; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2013 Apr; 20(4):1302-10. PubMed ID: 23161115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is radiotherapy necessary for intermediate risk ductal carcinoma in situ after breast conserving surgery?
    Kim T; Park HK; Lee KH; Kim KI; Lee KC; Ahn JS; Ko KP
    Springerplus; 2014; 3():405. PubMed ID: 25133091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes for Women with Minimal-Volume Ductal Carcinoma In Situ Completely Excised at Core Biopsy.
    Muhsen S; Barrio AV; Miller M; Olcese C; Patil S; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2017 Dec; 24(13):3888-3895. PubMed ID: 28828599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current view on ductal carcinoma in situ and importance of the margin thresholds: A review.
    Van Cleef A; Altintas S; Huizing M; Papadimitriou K; Van Dam P; Tjalma W
    Facts Views Vis Obgyn; 2014; 6(4):210-8. PubMed ID: 25593696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ductal carcinoma in situ and ductal carcinoma in situ with microinvasion: correlation of FDG uptake with histological and biological prognostic factors.
    Seo YY; Yoo IR; Park SY; Oh JK; Kim SH; Sohn HS
    Breast Cancer; 2017 May; 24(3):353-361. PubMed ID: 27312540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High PDGFRb Expression Predicts Resistance to Radiotherapy in DCIS within the SweDCIS Randomized Trial.
    Strell C; Folkvaljon D; Holmberg E; Schiza A; Thurfjell V; Karlsson P; Bergh J; Bremer T; Akslen LA; Wärnberg F; Östman A
    Clin Cancer Res; 2021 Jun; 27(12):3469-3477. PubMed ID: 33952629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.
    Boland GP; Chan KC; Knox WF; Roberts SA; Bundred NJ
    Br J Surg; 2003 Apr; 90(4):426-32. PubMed ID: 12673743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Biological Signature for Breast Ductal Carcinoma
    Bremer T; Whitworth PW; Patel R; Savala J; Barry T; Lyle S; Leesman G; Linke SP; Jirström K; Zhou W; Amini RM; Wärnberg F
    Clin Cancer Res; 2018 Dec; 24(23):5895-5901. PubMed ID: 30054280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of the Van Nuys Prognostic Index in ductal carcinoma in situ of the breast: a retrospective analysis.
    Asjoe FT; Altintas S; Huizing MT; Colpaert C; Marck EV; Vermorken JB; Tjalma WA
    Breast J; 2007; 13(4):359-67. PubMed ID: 17593040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12-gene DCIS score™ result.
    Alvarado M; Carter DL; Guenther JM; Hagans J; Lei RY; Leonard CE; Manders J; Sing AP; Broder MS; Cherepanov D; Chang E; Eagan M; Hsiao W; Schultz MJ
    J Surg Oncol; 2015 Jun; 111(8):935-40. PubMed ID: 26031501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic Assays in Ductal Carcinoma In Situ: Implications for Management Decisions.
    Gangi A; Topham A; Lee MC; Sun W; Laronga C
    South Med J; 2017 Oct; 110(10):649-653. PubMed ID: 28973706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
    Cornfield DB; Palazzo JP; Schwartz GF; Goonewardene SA; Kovatich AJ; Chervoneva I; Hyslop T; Schwarting R
    Cancer; 2004 Jun; 100(11):2317-27. PubMed ID: 15160334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [For which patients could we consider de-escalation in the management of ductal carcinomas in situ?].
    Azaïs H; Maingon P; Da Maïa E; Nikpayam M; Gonthier C; Belghiti J; Canlorbe G; Uzan C
    Gynecol Obstet Fertil Senol; 2019 Dec; 47(12):872-879. PubMed ID: 31562924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age.
    Van Zee KJ; Liberman L; Samli B; Tran KN; McCormick B; Petrek JA; Rosen PP; Borgen PI
    Cancer; 1999 Nov; 86(9):1757-67. PubMed ID: 10547549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment selection for patients with ductal carcinoma in situ (DCIS) of the breast using the University of Southern California/Van Nuys (USC/VNPI) prognostic index.
    Silverstein MJ; Lagios MD
    Breast J; 2015; 21(2):127-32. PubMed ID: 25600630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of the 12-Gene Breast DCIS Score
    Leonard CE; Tole SP; Turner MP; Bennett JP; Howell KT; Carter DL
    Front Oncol; 2021; 11():671047. PubMed ID: 34221987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ.
    Holland PA; Gandhi A; Knox WF; Wilson M; Baildam AD; Bundred NJ
    Br J Cancer; 1998; 77(1):110-4. PubMed ID: 9459154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fine tuning of the Van Nuys prognostic index (VNPI) 2003 by integrating the genomic grade index (GGI): new tools for ductal carcinoma in situ (DCIS).
    Altintas S; Toussaint J; Durbecq V; Lambein K; Huizing MT; Larsimont D; Van Marck E; Vermorken JB; Tjalma WA; Sotiriou C
    Breast J; 2011; 17(4):343-51. PubMed ID: 21645166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.
    Borgquist S; Zhou W; Jirström K; Amini RM; Sollie T; Sørlie T; Blomqvist C; Butt S; Wärnberg F
    BMC Cancer; 2015 Jun; 15():468. PubMed ID: 26062614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.